Clinical trial ACTION-1
| Kankers | |
|---|---|
| Organ | Neuroendocriene tumoren |
| Trial status | Trial open voor rekrutering |
| Trial type |
Interventioneel met experimenteel geneesmiddel
|
| Fase | Fase van de proef 1/3 |
| Academisch proef | Nee |
| Sponsor | RayzeBio Inc. |
| EudraCT Identifier | 2022-000507-12 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05477576 |
| Laatste update |